ArticleCureus2025
Investigating Factors Related to Length of Hospital Stay in Male Patients With Lung Cancer Undergoing Chemotherapy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background/purposeIn recent years, length of hospital stay has decreased, necessitating smoother discharge support. However, in patients with cancer receiving chemotherapy, longer hospital stays are associated with an increased incidence of adverse events. Moreover, no studies have examined indicators of the risk of prolonged hospitalization before treatment initiation. Specifically, reports clarifying the relationship between blood data, such as serum albumin (albumin) levels, and length of hospital stay are lacking. Therefore, this study aimed to investigate the characteristics of male patients with lung cancer undergoing chemotherapy and examine the factors related to length of hospital stay. MATERIALS AND
methodsThis was a cohort study of 42 male patients with lung cancer undergoing chemotherapy (mean age: 70 ± 6 years; body mass index: 22 ± 3 kg/m²; Charlson comorbidity index: 4 ± 2 points; performance status (PS): 1 ± 0). Measurement items included comorbidities, frailty, PS, the functional independence measure, the Barthel Index, and biochemical data. Multiple regression analysis was used to examine the influence of each indicator on length of hospital stay, with a significance level of 5%.
resultsMultiple regression analysis showed a significant association between albumin levels at admission and length of hospital stay (β = -0.512, t = -3.624, p < 0.001).
conclusionThe results of this study suggest that lower albumin levels at admission may lead to prolonged hospital stays in male patients with lung cancer undergoing chemotherapy. These findings indicate that a poor albumin status before chemotherapy may be related to length of hospital stay.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.